S5 E4: Interview with Prof Miriam Santer on BMJ Spironolactone for acne in GP; physician associates; once-weekly insulin; tirzepatide vs insulin for T2DM

NB Hot Topics Podcast

Welcome to the Hot Topics podcast from NB Medical with Dr Neal Tucker. The highlight of this episode is our interview with Prof Miriam Santer, lead author of recent research in the BMJ exploring the effectiveness of spironolactone for acne in women.
Does it work? Is it a treatment for general practice? And if so, is it safe, what monitoring is required, and where does it fit with current acne pathways?
In the news, we think about the current issues around physician associates in general practice. In research we have two papers on diabetes: first, in the Lancet, is a new once-weekly insulin injection as effective as a daily treatment for type 1 diabetes; and second, in JAMA, is the additional tirzepatide better than prandial insulin in addition to glargine for managing type 2 diabetes?
References

Eczema Care Online
BMJ Spiro for acne
Lancet Once weekly insulin vs daily insulin in T1DM
JAMA Tirzepatide vs prandial insulin in T2DM
www.nbmedical.com/podcast

Rozdziały

1. Introduction (00:00:00)

2. Physician associates (00:02:08)

3. Once weekly basal insulin vs daily basal insulin for T1DM (00:07:30)

4. Which option to add to basal insulin in T2DM (00:12:13)

5. Interview with Prof Miriam Santer: spironolactone for acne in women in general practice (00:16:48)